The 1315 Capital investment team combines financial and business development expertise with deep industry knowledge to support the growth of our portfolio companies.
1315 Capital employs a unique Operating Team model to navigate diligence, drive decisions, and achieve premium exits.
1315 Capital has a deep network that it leverages for management talent, advisors, deal sourcing, diligence, and boards roles.
July 31, 2020
July 20, 2020
June 25, 2020
Provider of AI-enabled decision support technology for global life sciences sales and marketing teams.
Medical technology company providing hydrophilic coatings to medical device manufacturers.
Cost-containment service company providing hospitals with turn key liquidation of used equipment.
Special needs equipment and supply company that serves the pediatric and adult special needs population.
Cosmeceutical company providing natural, mineral-based approach to skin protection and skin health.
Dermatology company committed to delivering innovative prescription therapies to dermatologists.
Oncology diagnostics company that provides oncologists and pathologists with comprehensive testing solutions in hematology and solid tumor molecular profiling.
Multi-center services company providing transcranial magnetic stimulation to mental health patients.
Cost-containment service company focused on reprocessing single-use medical devices.
Bioinformatics company providing evidence-based, clinically beneficial molecular diagnostic tests and pathology services.
Specialty pharmaceutical company focused on nutraceutical and women’s health products.
Medical technology company offering ultrasonic surgical tools and advanced wound care products to healthcare providers.
Medical device company focused on the orthopedic oncology market.
Medical device company providing functional electrical stimulation to neurological rehabilitation patients.
Forensic genomics company providing next-generation sequencing equipment, solutions, and software.